3002.13.00.10/Adalimumab Monoclonal Antibody/Canada

Adalimumab Monoclonal Antibody from Canada

Adalimumab (Humira) is a fully human monoclonal antibody against TNF-alpha, treating autoimmune diseases like rheumatoid arthritis. It is imported as unmixed bulk under HTS 3002.13.0010, meeting the definition of immunological products directly regulating immune processes via biotech-derived proteins. Not in retail forms or measured doses.

Duty Rate — Canada → United States

0%

Rate breakdown

9903.03.030%Articles the product of any country, as provided for in subdivision (aa)(ii) of U.S. note 2 to this subchapter
Calculate with your customs valueVerify classification with AI

Import Tips

• Submit Form FDA 2877 for biologics and ensure biosimilar status if applicable for abbreviated pathways

• Monitor for stability data in import declarations to confirm non-degraded bulk product

Adalimumab Monoclonal Antibody from Canada — Import Duty Rate | HTS 3002.13.00.10